Can Buspirone (an anxiolytic medication) cause erratic behavior in patients, particularly those with a history of psychiatric conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Buspirone Cause Erratic Behavior?

Yes, buspirone can cause erratic behavior, though this is uncommon; the FDA label specifically warns about a syndrome of restlessness and agitation appearing shortly after treatment initiation, and rare cases of worsening psychosis have been documented, particularly in patients with pre-existing psychiatric conditions. 1, 2

Key Safety Concerns from FDA Labeling

The FDA-approved prescribing information identifies several behavioral concerns related to buspirone's dopaminergic effects 1:

  • Restlessness syndrome: A syndrome of restlessness appearing shortly after initiation of treatment has been reported in a small fraction of buspirone-treated patients, potentially explained by increased central noradrenergic activity or dopaminergic effects (akathisia) 1

  • Withdrawal-related agitation: The syndrome of withdrawal from prior sedative/hypnotic/anxiolytic drugs can manifest as irritability, anxiety, agitation, insomnia, and tremor when transitioning to buspirone 1

  • Dopamine receptor concerns: Because buspirone binds to central dopamine receptors, there is potential for acute and chronic changes in dopamine-mediated neurological function, though clinical trials have not identified significant neuroleptic-like activity 1

Evidence in Psychiatric Populations

Patients with psychotic disorders are at particular risk 2:

  • A 2023 case report documented buspirone worsening psychosis in a patient with schizoaffective disorder, with increased aggression, odd behaviors, and paranoia occurring on two separate administration trials 2

  • Buspirone acts as an antagonist at presynaptic dopamine D2, D3, and D4 receptors, and contrary to expected outcomes, resulted in substantial increases in dopaminergic metabolites rather than antipsychotic effects 2

  • The route of administration matters: intranasal administration leads to faster drug absorption and increased bioavailability (compared to ~4% oral bioavailability after first-pass metabolism), potentially enhancing adverse effects 2

Clinical Context from Guidelines

Guidelines for managing agitation note important distinctions 3:

  • Buspirone is described as "useful only in patients with mild to moderate agitation" and "may take 2 to 4 weeks to become effective" 3

  • In contrast, benzodiazepines carry a warning that "paradoxic agitation occurs in about 10% of patients" 3

  • For acute behavioral emergencies, buspirone is not recommended due to its delayed onset of action 3

Positive Evidence for Behavioral Disorders

Paradoxically, buspirone may reduce certain types of erratic behavior 4, 5:

  • In patients with mental retardation and severe challenging behavior (aggressive outbursts, self-injurious behavior, impulsivity), buspirone 20-50 mg daily was effective in reducing behavioral disturbances and improving sociability 4

  • This may result from a de-arousing phenomenon mediated via corticosteroid-dependent stress homeostatic mechanisms 4

Clinical Recommendations

Monitor closely for behavioral changes, especially in the following scenarios:

  • First 1-2 weeks of treatment: Watch for restlessness syndrome or paradoxical agitation 1

  • Patients with psychotic disorders: Exercise extreme caution or avoid buspirone entirely, as worsening psychosis with increased aggression and paranoia has been documented 2

  • Patients transitioning from benzodiazepines: Gradual withdrawal from prior CNS depressants is essential, as buspirone will not block withdrawal symptoms that can include agitation and irritability 1

  • Patients demanding immediate relief: Buspirone's 1-2 week lag time to anxiolytic effect may lead to frustration and non-compliance 6, 7

Important Caveats

  • The overall side effect profile of buspirone is favorable compared to benzodiazepines, with sedation occurring much less frequently 6

  • Clinical trials have demonstrated buspirone does not impair psychomotor or cognitive function and has limited potential for abuse and dependence 6, 7

  • Most patients tolerate buspirone well, but unpredictable CNS effects in individual patients necessitate caution with activities requiring alertness until response is established 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.